Association between decreased kidney function and endotoxin receptor CD14 C-159T polymorphism among Japanese health check-up examinees

Renal Failure

Volumn 29, Issue 8, 2007, Pages 967-972

  Okada, Rieko ^a   Suzuki, Koji ^b   Ito, Yoshinori ^a   Nishio, Kazuko ^a   Ishida, Yoshiko ^a   Kawai, Sayo ^a   Goto, Yasuyuki ^a   Naito, Mariko ^a   Wakai, Kenji ^a   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

CD14; Chronic kidney disease; Glomerular filtration rate; Lipopolysaccharide; Polymorphism (genetics)

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CONFIDENCE INTERVAL; DIETARY INTAKE; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; HETEROZYGOTE; HUMAN; JAPAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC SCREENING; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36849009836     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701641686     Document Type: Article

References (24)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-S266.
2. Sarnak MJ, Levey AS, Schoolwerth AC, et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169.
3. Baldini M, Lohman IC, Halonen M, et al. A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999;20:976-983.
4. Kabesch M, Hasemann K, Schickinger V, et al. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy. 2004;59:520-525.
5. Loppnow H, Stelter F, Schonbeck U, et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun. 1995;63:1020-1026.
6. Unkelbach K, Gardemann A, Kostrzewa M, et al. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol. 1999;19:932-938.
7. Nishimura S, Zaitsu M, Hara M, et al. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr. 2003;143:357-362.
8. Hamajima N, Saito T, Matsuo K, et al. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res. 2000;91:865-868.
9. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254.
10. Stenvinkel P, Ketteler M, Johnson RJ, et al. IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int. 2005;67:1216-1233.
11. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol. 2001;167:5838-5844.
12. Gazouli M, Mantzaris G, Kotsinas A, et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol. 2005;11:681-685.
13. Risley P, Jerrard-Dunne P, Sitzer M, et al. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: The Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2003;34:600-604.
14. Losito A, Kalidas K, Santoni S, et al. Association of the - 159C/T polymorphism of the endotoxin receptor (CD14) with carotid artery disease and cardiovascular mortality in dialysis patients. Blood Purif. 2005;23:128-133.
15. Yoon HJ, Shin JH, Yang SH, et al. Association of the CD14 gene-159C polymorphism with progression of IgA nephropathy. J Med Genet. 2003;40:104-108.
16. Amar J, Ruidavets JB, Bal dit Sollier C, et al. CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens. 2004;22:1523-1528.
17. Vercelli D. Learning from discrepancies: CD14 polymorphisms, atopy and the endotoxin switch. Clin Exp Allergy. 2003;33:153-155.
18. Ushiyama C, Nakamura T, Suzuki S, et al. Effect of mizoribine on serum IgE concentration in patients with IgA nephropathy. Nephron. 2001;87:194-195.
19. Nakada TA, Hirasawa H, Oda S, et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res. 2005;129:322-328.
20. McCullough PA, Jurkovitz CT, Pergola PE, et al., for the KEEP Investigators. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007;167:1122-1129.
21. Rahman M, Pressel S, Davis BR, et al. ALLHAT Collaborative Research Group. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med. 2006;144:172-180.
22. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
23. Morrissey J, Guo G, McCracken R, et al. Induction of CD14 in tubular epithelial cells during kidney disease. J Am Soc Nephrol. 2000;11:1681-1690.
24. Scherberich JE, Nockher WA. Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure. Nephrol Dial Transplant. 2000;15:574-578.